Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.40 USD
341.30 M USD
2.36 B USD
96.83 M
About Neurocrine Biosciences, Inc.
Sector
CEO
Kyle W. Gano
Headquarters
San Diego
Website
Founded
1992
FIGI
BBG00JVRFVK7
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 0K6R is featured.
Frequently Asked Questions
The current price of 0K6R is 114.20 USD — it has increased by 0.64% in the past 24 hours. Watch NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stocks are traded under the ticker 0K6R.
0K6R stock has fallen by −2.61% compared to the previous week, the month change is a −24.70% fall, over the last year NEUROCRINE BIOSCIENCES INC COM STK USD0.001 has showed a −14.18% decrease.
We've gathered analysts' opinions on NEUROCRINE BIOSCIENCES INC COM STK USD0.001 future price: according to them, 0K6R price has a max estimate of 192.00 USD and a min estimate of 138.00 USD. Watch 0K6R chart and read a more detailed NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock forecast: see what analysts think of NEUROCRINE BIOSCIENCES INC COM STK USD0.001 and suggest that you do with its stocks.
0K6R reached its all-time high on Aug 1, 2024 with the price of 157.80 USD, and its all-time low was 67.30 USD and was reached on Jan 2, 2019. View more price dynamics on 0K6R chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0K6R stock is 2.04% volatile and has beta coefficient of 0.49. Track NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock price on the chart and check out the list of the most volatile stocks — is NEUROCRINE BIOSCIENCES INC COM STK USD0.001 there?
Today NEUROCRINE BIOSCIENCES INC COM STK USD0.001 has the market capitalization of 11.27 B, it has decreased by −0.33% over the last week.
Yes, you can track NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financials in yearly and quarterly reports right on TradingView.
NEUROCRINE BIOSCIENCES INC COM STK USD0.001 is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
0K6R earnings for the last quarter are 1.00 USD per share, whereas the estimation was 1.61 USD resulting in a −37.72% surprise. The estimated earnings for the next quarter are 0.86 USD per share. See more details about NEUROCRINE BIOSCIENCES INC COM STK USD0.001 earnings.
NEUROCRINE BIOSCIENCES INC COM STK USD0.001 revenue for the last quarter amounts to 627.70 M USD, despite the estimated figure of 629.46 M USD. In the next quarter, revenue is expected to reach 602.84 M USD.
0K6R net income for the last quarter is 103.10 M USD, while the quarter before that showed 129.80 M USD of net income which accounts for −20.57% change. Track more NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financial stats to get the full picture.
No, 0K6R doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 10, 2025, the company has 1.80 K employees. See our rating of the largest employees — is NEUROCRINE BIOSCIENCES INC COM STK USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEUROCRINE BIOSCIENCES INC COM STK USD0.001 EBITDA is 610.10 M USD, and current EBITDA margin is 26.50%. See more stats in NEUROCRINE BIOSCIENCES INC COM STK USD0.001 financial statements.
Like other stocks, 0K6R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEUROCRINE BIOSCIENCES INC COM STK USD0.001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEUROCRINE BIOSCIENCES INC COM STK USD0.001 stock shows the sell signal. See more of NEUROCRINE BIOSCIENCES INC COM STK USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.